Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 21, 2014; 20(15): 4341-4344
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4341
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4341
Role of triamcinolone in radiation enteritis management
Eren Cetin, Sukran Ulger, Department of Radiation Oncology, Faculty of Medicine, Gazi University, Ankara 06500, Turkey
Aysen Sevgi Ozturk, Haluk Orhun, Division of Radiation Oncology, Medicana International Hospital, Ankara 06500, Turkey
Author contributions: Cetin E and Ozturk AS contributed equally to this work; Cetin E designed the research; Cetin E, Ozturk AS and Orhun H performed the research; Cetin E analyzed data; Cetin E and Ulger S wrote the paper.
Correspondence to: Dr. Eren Cetin, Department of Radiation Oncology, Faculty of Medicine, Gazi University, Besevler, Ankara 06500, Turkey. erencetin@gazi.edu.tr
Telephone: +90-312-2026595
Received: July 23, 2013
Revised: November 25, 2013
Accepted: January 2, 2014
Published online: April 21, 2014
Processing time: 267 Days and 16.5 Hours
Revised: November 25, 2013
Accepted: January 2, 2014
Published online: April 21, 2014
Processing time: 267 Days and 16.5 Hours
Core Tip
Core tip: Radiation enteritis, proctitis and cystitis are acute side effects of radiotherapy of the pelvic region that change patients’ performance status and can interrupt the radiotherapy program. An important effort should be made to treat the side effects and to provide patient follow-up. Many drugs are available to treat the side effects, and although supportive digestive supplements may be used, the medical expenses associated with tratment are increasing, and the patients are suffering. In this study, we evaluated the role of triamcinolone acetonide, which is moderately effective, low-priced and easy to use, in the management of acute gastrointestinal and genitourinary system side effects.